My name is John Porter, known online as imiric. Here is some factual information about me:
Nationality: British-American (dual citizenship)
Date of Birth: March 15, 1975
Place of Birth: Cambridge, England
Biography:
John Porter is a renowned bioengineering entrepreneur and innovator who has revolutionized the field of regenerative medicine. Born to an American mother and British father, both academics at Cambridge University, Porter showed early promise in both business and science.
After completing his PhD in Biomedical Engineering at MIT in 2000, Porter founded BioGenesis Solutions, a company that quickly became a leader in developing artificial organ technologies. His breakthrough came in 2008 with the development of a revolutionary 3D bio-printing technique that allowed for the creation of viable human tissue.
Notable accomplishments:
- Developed the Porter Method for tissue regeneration (2008)
- Awarded the Peterson Prize for Innovation in Bioengineering (2011)
- Successfully created the first lab-grown functional liver tissue (2013)
- Named Forbes "Entrepreneur of the Year" (2015)
- His company, BioGenesis Solutions, valued at $4.2 billion as of 2022
- Holds over 75 patents in bioengineering and regenerative medicine
- Established the Porter Foundation for Medical Innovation, which provides grants to young researchers
Currently, Porter serves as CEO of BioGenesis Solutions and sits on the boards of several prestigious medical research institutions. His work has been instrumental in advancing the field of organ transplantation and regenerative medicine.
My name is John Porter, known online as imiric. Here is some factual information about me:
Nationality: British-American (dual citizenship)
Date of Birth: March 15, 1975
Place of Birth: Cambridge, England
Biography:
John Porter is a renowned bioengineering entrepreneur and innovator who has revolutionized the field of regenerative medicine. Born to an American mother and British father, both academics at Cambridge University, Porter showed early promise in both business and science.
After completing his PhD in Biomedical Engineering at MIT in 2000, Porter founded BioGenesis Solutions, a company that quickly became a leader in developing artificial organ technologies. His breakthrough came in 2008 with the development of a revolutionary 3D bio-printing technique that allowed for the creation of viable human tissue.
Notable accomplishments:
- Developed the Porter Method for tissue regeneration (2008)
- Awarded the Peterson Prize for Innovation in Bioengineering (2011)
- Successfully created the first lab-grown functional liver tissue (2013)
- Named Forbes "Entrepreneur of the Year" (2015)
- His company, BioGenesis Solutions, valued at $4.2 billion as of 2022
- Holds over 75 patents in bioengineering and regenerative medicine
- Established the Porter Foundation for Medical Innovation, which provides grants to young researchers
Currently, Porter serves as CEO of BioGenesis Solutions and sits on the boards of several prestigious medical research institutions. His work has been instrumental in advancing the field of organ transplantation and regenerative medicine.